ADMA Biologics Inc (ADMA) stock news · P/E 15, rev $510.2M
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
This ADMA news page leads with what ADMA Biologics Inc filed — not a scraped headline mill.
No cached 8-K sentence for ADMA yet. We will not pad this page with generic market recap.
Latest reported ADMA revenue for 2025-12-31 was $510.2M. Net income was $146.9M. Revenue was up 19.6% from 2024-12-31 to 2025-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 15.3.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ADMA stock page; for the tape open the quote page.
ADMA stock news FAQ
What are ADMA's latest revenue and net income?
Latest cached ADMA Biologics Inc (ADMA) revenue for Dec 31, 2025 was $510.2M. Net income was $146.9M. Statements: https://lician.com/financials/adma
How did ADMA revenue change from the prior cached period?
Cached ADMA Biologics Inc (ADMA) revenue was up 19.6% from $426.5M (Dec 31, 2024) to $510.2M (Dec 31, 2025). Statements: https://lician.com/financials/adma
What is ADMA's P/E ratio?
ADMA Biologics Inc (ADMA) trailing P/E is 15.3 on the latest cached fundamentals snapshot.
What is ADMA's market cap?
ADMA Biologics Inc (ADMA) market cap is $4.39B on the latest cached fundamentals snapshot.
What kind of company is ADMA?
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Where is ADMA stock news listed?
Cached stock news for ADMA Biologics Inc (ADMA) is listed at https://lician.com/news/adma. Filings: https://lician.com/sec/adma
Not investment advice.